Anzeige
Mehr »
Login
Dienstag, 26.10.2021 Börsentäglich über 12.000 News von 675 internationalen Medien
Neue Kursparty? Innovation inmitten des Rollouts: Spekulation auf ganz starke Zahlen
Anzeige

Indizes

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Aktien

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Xetra-Orderbuch

Fonds

Kurs

%

Devisen

Kurs

%

Rohstoffe

Kurs

%

Themen

Kurs

%

Erweiterte Suche

WKN: A2PKX1 ISIN: SE0012570448 Ticker-Symbol: 5J6 
Frankfurt
26.10.21
08:04 Uhr
0,861 Euro
+0,028
+3,36 %
Branche
Gesundheitswesen
Aktienmarkt
Sonstige
1-Jahres-Chart
OSSDSIGN AB Chart 1 Jahr
5-Tage-Chart
OSSDSIGN AB 5-Tage-Chart

Aktuelle News zur OSSDSIGN Aktie

  • Alle
  • Pressemitteilungen
  • Empfehlungen
  • Chartanalysen
  • Berichte
ZeitAktuelle Nachrichten
Sprache: Alle DE EN
LeserMedien
07.10.OSSDSIGN AB: First patients in the U.S. treated with OssDsign Catalyst2
04.10.Karolinska Development AB (publ): Karolinska Development's portfolio company OssDsign receives expanded FDA market clearance for OssDsign Cranial PSI193STOCKHOLM, SWEDEN, 4 October 2021 Karolinska Development AB (Nasdaq Stockholm: KDEV) today announces that its portfolio company OssDsign AB has received an expanded marketing authorization from the...
► Artikel lesen
OSSDSIGN Aktie jetzt für 0€ handeln
04.10.OSSDSIGN AB: OssDsign receives expanded FDA market clearance for OssDsign Cranial PSI2
09.09.Karolinska Development AB (publ): Karolinska Development's portfolio company OssDsign includes first patient to a clinical trial of the synthetic bone graft OssDsign Catalyst293STOCKHOLM, SWEDEN - September 9, 2021. Karolinska Development AB (Nasdaq Stockholm: KDEV) announces today that the portfolio company OssDsign AB has included the first patient to the clinical trial...
► Artikel lesen
08.09.OSSDSIGN AB: First patient included in OssDsign's clinical study of the synthetic bone graft OssDsign Catalyst1
16.08.Karolinska Development AB (publ): Karolinska Development's portfolio company OssDsign launches the synthetic bone graft OssDsign Catalyst on the U.S. market311STOCKHOLM, SWEDEN - August 16, 2021. Karolinska Development AB (Nasdaq Stockholm: KDEV) announces today that the portfolio company OssDsign AB has launched OssDsign Catalyst in the U.S. The product...
► Artikel lesen
16.08.OSSDSIGN AB: OssDsign Catalyst now available on the U.S. market2
10.08.OSSDSIGN AB: OssDsign Partners with Red One Medical to Provide Reconstructive Cranial Solutions and Synthetic Bone Grafts to US Veterans and Military Members1
08.07.OSSDSIGN AB: OssDsign Selected to Exhibit Cranial PSI at Vizient Innovative Technology Exchange2
01.07.OSSDSIGN AB: OssDsign's Management and Board of Directors increase their long-term commitment through acquisiton of warrants for a total amount of approximately SEK 1.3 million2
22.06.Annual General Meeting held in OssDsign AB1
08.06.OSSDSIGN AB: OssDsign publishes Annual Report 20202
02.06.OSSDSIGN AB: New preclinical data shows that OssDsign's innovative synthetic bone graft outperforms a comparable device in bone formation following spinal fusion surgery2
21.05.Notice to attend the Annual General Meeting in OssDsign AB2
19.05.Nasdaq Stockholm AB: Last day of trading in paid subscription shares (BTA) of OssDsign AB (224/21)260Trading in OssDsign AB paid subscription shares is to cease. The last trading day is May 25, 2021. Short name: OSSD BTA --------------------------- ISIN code: SE0015938113 --------------------------- Orderbook...
► Artikel lesen
12.05.Karolinska Development AB (publ): Karolinska Development's portfolio company OssDsign raises SEK 270 million through an oversubscribed rights issue339STOCKHOLM, SWEDEN - May 12, 2021. Karolinska Development AB (Nasdaq Stockholm: KDEV) announces today that its portfolio company OssDsign completed a successful rights issue of shares with preferential...
► Artikel lesen
20.04.Nasdaq Stockholm AB: Listing of subscription rights and paid subscription shares of OssDsign AB (170/21)296With effect from April 21, 2021, the subscription rights in OssDsign AB will be traded on First North Growth Market. Trading will continue up until and including May 04, 2021. Instrument: Subscription...
► Artikel lesen
14.04.XFRA CAPITAL ADJUSTMENT INFORMATION - 14.04.2021753CAPITAL ADJUSTMENT INFORMATION - 14.04.2021:Das Instrument 80E ES0180918015 GRUPO EMPRES. SAN JOSE EQUITY wird ex Kapitalmassnahme gehandelt am 14.04.2021 The instrument 80E ES0180918015 GRUPO EMPRES....
► Artikel lesen
02.03.Karolinska Development AB (publ): Karolinska Development's portfolio company OssDsign announces a fully guaranteed rights issue and launches new corporate strategy393STOCKHOLM, SWEDEN - March 2, 2021. Karolinska Development AB (Nasdaq Stockholm: KDEV) announces today that its portfolio company OssDsign has decided to carry out a fully guaranteed rights issue of...
► Artikel lesen
04.11.20Karolinska Development AB (publ): Karolinska Development's portfolio company OssDsign enters USD 4 billion bone graft market by acquiring Sirakoss Ltd308STOCKHOLM, SWEDEN - November 4, 2020. Karolinska Development AB (Nasdaq Stockholm: KDEV) announces today that its portfolio company OssDsign has acquired the bone graft substitute company Sirakoss Ltd....
► Artikel lesen
20 Nachrichten in den letzten 12 Monaten
Ich würde die Aktie auf Sicht von 6 Monaten
VerkaufenHaltenKaufen
■ Verkaufen
■ Halten
■ Kaufen
1,1,1